Novo Nordisk Sues Lilly Over Weight Loss Ads | Dayton News

Dayton News Today | 2 Min News | The Daily News Now! · Jul 21, 2026 · 1m

Novo Nordisk is suing Eli Lilly over alleged false advertising in weight-loss drug claims, accusing them of cherry-picking data and comparing higher doses of their own drugs against lower doses of Novo’s Wegovy and Ozempic — a move Novo says is deceptive. After a cease-and-desist letter went unanswered, Novo is demanding a court order to halt the ads and force a correction campaign, threatening a preliminary injunction if Lilly doesn’t comply. The legal showdown underscores the fierce, high-stakes battle for dominance in the booming weight-loss drug market, where every ad and study can make…